Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
VMD

VMD - Viemed Healthcare Inc Stock Price, Fair Value and News

$7.39-0.06 (-0.81%)
Market Closed

70/100

VMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

70/100

VMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$9.24

Target 3M

$7.76

Target 6M

$8.22

VMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VMD Price Action

Last 7 days

-1.3%

Last 30 days

-0.7%

Last 90 days

15.7%

Trailing 12 Months

-11.1%

VMD RSI Chart

VMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

VMD Valuation

Market Cap

281.0M

Price/Earnings (Trailing)

20.38

Price/Sales (Trailing)

1.1

EV/EBITDA

12.98

Price/Free Cashflow

52.17

VMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$9.24

Target 3M

$7.76

Target 6M

$8.22

VMD Fundamentals

VMD Revenue

Revenue (TTM)

254.8M

Rev. Growth (Yr)

23.98%

Rev. Growth (Qtr)

14.05%

VMD Earnings

Earnings (TTM)

13.8M

Earnings Growth (Yr)

-9.41%

Earnings Growth (Qtr)

8.09%

VMD Profitability

EBT Margin

7.88%

Return on Equity

10.32%

Return on Assets

6.81%

Free Cashflow Yield

1.92%

VMD Investor Care

Buy Backs (1Y)

2.36%

Diluted EPS (TTM)

0.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025232.8M240.9M254.8M0
2024194.0M205.7M214.3M224.3M
2023146.1M156.1M169.8M183.0M
2022120.9M126.8M133.3M138.8M
2021135.9M120.5M116.3M117.1M
202085.9M108.5M121.6M131.3M
201968.6M73.7M77.2M80.3M
201800064.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About Viemed Healthcare Inc

VMD
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
 CEO
 WEBSITEviemed.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES974

Viemed Healthcare Inc Frequently Asked Questions

VMD is the stock ticker symbol of Viemed Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Viemed Healthcare Inc is 280.95 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check VMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether VMD is over valued or under valued. Whether Viemed Healthcare Inc is cheap or expensive depends on the assumptions which impact Viemed Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VMD.

As of Wed Jan 28 2026, VMD's PE ratio (Price to Earnings) is 20.38 and Price to Sales (PS) ratio is 1.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VMD PE ratio will change depending on the future growth rate expectations of investors.